Calidi Biotherapeutics, Inc., a biotechnology company specializing in biological products, has increased its stock offering capacity under its existing Sales Agreement with Ladenburg Thalmann & Co.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Ladenburg Thalmann has recently raised Evaxion Biotech A S ADR Representing 10 Ord Shs (EVAX) stock to Buy rating, as announced on April 2, 2024, according to Finviz. Analyst ratings are significant ...

Orchid Island Capital Inc (ORC) stock saw a modest uptick, ending the day at $8.35 which represents a slight increase of $0.32 or 3.99% from the prior close of $8.03. The stock opened at $7.92 and ...

Ladenburg Thalmann analyst Paul Fremont upgraded shares of Entergy Corp (NYSE:ETR) from Neutral to Buy, setting a price target of $86.50. Fremont's decision comes as a response to the stock's recent ...